World Diabetes Foundation

Part of Novo Nordisk’s contribution to promoting access to care is our continued long-term financial commitment to the  (WDF).

The World Diabetes Foundation was established by Novo Nordisk in 2002 as an independent trust dedicated to the prevention and treatment of diabetes in developing countries. The Foundation supports sustainable partnerships and acts as a catalyst to help others do more.

Novo Nordisk has donated a total of DKK 1.69 billion (USD 277 million) to the Foundation, to be allocated in the period 2001–2024.

Visit the .

 

Access to diabetes care in low- and middle-income countries

Why do 80% of people with diabetes live in developing countries? And what can be done about it? See this film and learn how partnerships are improving health systems and lives in Tanzania, and worldwide.

 

pk10机器人 江苏快3 江苏快3 北京赛车PK10计划 期货配资 极速3D彩票 江苏快三质合走势图 北京快3 江苏快3 股票配资